ALKS – alkermes plc - ordinary shares (US:NASDAQ)
Stock Stats
News
Alkermes (NASDAQ:ALKS) had its price target raised by analysts at Bank of America Corporation from $33.00 to $34.00. They now have a "neutral" rating on the stock.
Alkermes plc Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
Is Alkermes (ALKS) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Alkermes (NASDAQ:ALKS) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Form 4 Alkermes plc. For: Feb 18 Filed by: Parisi Samuel Joseph
Form 4 Alkermes plc. For: Feb 18 Filed by: Nichols Christian Todd
Form 4 Alkermes plc. For: Feb 18 Filed by: Jackson Blair Curtis
Form 4 Alkermes plc. For: Feb 18 Filed by: Hopkinson Craig C.
Form 4 Alkermes plc. For: Feb 18 Filed by: Gaffin David Joseph
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.